The Certificate of Advanced Studies in Prostate Cancer (CAS-Pr), Cohort 3, organized by the European School of Oncology (ESO) in collaboration with the Università della Svizzera italiana (USI), will begin in December 2026, with its first in-person seminar taking place on December 2–5, 2026, at PROSCA 2026 in Amsterdam, the Netherlands.

The 16-month postgraduate programme is designed for oncology professionals involved in prostate cancer care and combines six online modules with three mandatory in-person seminars.

The curriculum aims to strengthen both clinical expertise and scientific competence in prostate cancer, with subsequent seminars planned for the ESO Learning to Care Seminar in November 2027 and APCCC 2028 in Lugano, Switzerland, where the final examination will also take place. Admission is competitive and limited to 25 participants, and successful candidates will receive an academic certificate jointly issued by ESO and USI.